Robeco Institutional Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $437M | Buy |
3,459,893
+105,499
| +3% | +$13.9M | 0.54% | 35 |
|
|
2026
Q1 | $468M | Sell |
3,354,394
-339,208
| -9% | -$47.5M | 0.67% | 23 |
|
|
2025
Q4 | $453M | Sell |
3,693,602
-108,349
| -3% | -$13.2M | 0.65% | 22 |
|
|
2025
Q3 | $422M | Buy |
3,801,951
+59,295
| +2% | +$6.74M | 0.61% | 23 |
|
|
2025
Q2 | $415M | Buy |
3,742,656
+417,237
| +13% | +$44.4M | 0.67% | 22 |
|
|
2025
Q1 | $373M | Sell |
3,325,419
-97,963
| -3% | -$10.1M | 0.72% | 24 |
|
|
2024
Q4 | $316M | Sell |
3,423,382
-5,726
| -0.2% | -$516K | 0.6% | 31 |
|
|
2024
Q3 | $287M | Sell |
3,429,108
-57,915
| -2% | -$4.42M | 0.57% | 32 |
|
|
2024
Q2 | $239M | Sell |
3,487,023
-96,067
| -3% | -$6.41M | 0.51% | 37 |
|
|
2024
Q1 | $262M | Sell |
3,583,090
-16,317
| -0.5% | -$1.25M | 0.57% | 33 |
|
|
2023
Q4 | $292M | Sell |
3,599,407
-145,089
| -4% | -$11.3M | 0.71% | 29 |
|
|
2023
Q3 | $281M | Sell |
3,744,496
-111,284
| -3% | -$8.56M | 0.75% | 21 |
|
|
2023
Q2 | $297M | Sell |
3,855,780
-8,494
| -0.2% | -$677K | 0.78% | 16 |
|
|
2023
Q1 | $321M | Buy |
3,864,274
+196,051
| +5% | +$16.2M | 0.87% | 15 |
|
|
2022
Q4 | $315M | Buy |
3,668,223
+27,383
| +0.8% | +$2.17M | 0.91% | 13 |
|
|
2022
Q3 | $225M | Buy |
3,640,840
+39,469
| +1% | +$2.49M | 0.73% | 27 |
|
|
2022
Q2 | $223M | Sell |
3,601,371
-101,560
| -3% | -$6.29M | 0.69% | 30 |
|
|
2022
Q1 | $220M | Buy |
3,702,931
+177,799
| +5% | +$11.4M | 0.52% | 41 |
|
|
2021
Q4 | $256M | Buy |
3,525,132
+1,528,101
| +77% | +$105M | 0.54% | 45 |
|
|
2021
Q3 | $139M | Sell |
1,997,031
-125,474
| -6% | -$8.82M | 0.31% | 86 |
|
|
2021
Q2 | $146M | Buy |
2,122,505
+75,692
| +4% | +$5.05M | 0.32% | 80 |
|
|
2021
Q1 | $132M | Sell |
2,046,813
-27,684
| -1% | -$1.79M | 0.33% | 84 |
|
|
2020
Q4 | $121M | Buy |
2,074,497
+74,318
| +4% | +$4.48M | 0.32% | 81 |
|
|
2020
Q3 | $126M | Buy |
2,000,179
+578,454
| +41% | +$40.1M | 0.39% | 64 |
|
|
2020
Q2 | $109M | Buy |
1,421,725
+152,290
| +12% | +$11.7M | 0.37% | 65 |
|
|
2020
Q1 | $94.9M | Sell |
1,269,435
-275,926
| -18% | -$19.1M | 0.38% | 58 |
|
|
2019
Q4 | $100M | Buy |
1,545,361
+74,637
| +5% | +$4.86M | 0.32% | 72 |
|
|
2019
Q3 | $93.2M | Buy |
1,470,724
+106,258
| +8% | +$6.95M | 0.33% | 69 |
|
|
2019
Q2 | $92.2M | Sell |
1,364,466
-6,703
| -0.5% | -$441K | 0.33% | 71 |
|
|
2019
Q1 | $89.1M | Buy |
1,371,169
+261,074
| +24% | +$17.4M | 0.33% | 71 |
|
|
2018
Q4 | $69.3M | Buy |
1,110,095
+31,481
| +3% | +$2.2M | 0.31% | 79 |
|
|
2018
Q3 | $83.3M | Buy |
1,078,614
+114,525
| +12% | +$8.65M | 0.33% | 80 |
|
|
2018
Q2 | $68.3M | Buy |
964,089
+42,385
| +5% | +$2.99M | 0.31% | 88 |
|
|
2018
Q1 | $69.5M | Buy |
921,704
+163,262
| +22% | +$13M | 0.33% | 86 |
|
|
2017
Q4 | $54.3M | Buy |
758,442
+290,556
| +62% | +$22.1M | 0.28% | 98 |
|
|
2017
Q3 | $37.9M | Buy |
467,886
+17,059
| +4% | +$1.3M | 0.24% | 116 |
|
|
2017
Q2 | $31.9M | Buy |
450,827
+74,211
| +20% | +$4.94M | 0.21% | 135 |
|
|
2017
Q1 | $25.6M | Buy |
376,616
+126,953
| +51% | +$8.93M | 0.17% | 156 |
|
|
2016
Q4 | $17.9M | Buy |
249,663
+20,403
| +9% | +$1.52M | 0.14% | 187 |
|
|
2016
Q3 | $18.1M | Buy |
229,260
+117,098
| +104% | +$9.51M | 0.13% | 190 |
|
|
2016
Q2 | $9.36M | Sell |
112,162
-14,711
| -12% | -$1.31M | 0.07% | 256 |
|
|
2016
Q1 | $11.7M | Buy |
126,873
+14,266
| +13% | +$1.29M | 0.09% | 222 |
|
|
2015
Q4 | $11.4M | Sell |
112,607
-469,164
| -81% | -$48.8M | 0.1% | 222 |
|
|
2015
Q3 | $57.1M | Buy |
581,771
+203,249
| +54% | +$22.6M | 0.44% | 65 |
|
|
2015
Q2 | $44.3M | Buy |
378,522
+11,659
| +3% | +$1.27M | 0.34% | 90 |
|
|
2015
Q1 | $36M | Buy |
366,863
+142,085
| +63% | +$14.4M | 0.27% | 109 |
|
|
2014
Q4 | $21.2M | Buy |
224,778
+134,216
| +148% | +$13.9M | 0.15% | 173 |
|
|
2014
Q3 | $9.64M | Sell |
90,562
-4,617
| -5% | -$452K | 0.07% | 259 |
|
|
2014
Q2 | $7.89M | Buy |
95,179
+5,969
| +7% | +$465K | 0.06% | 268 |
|
|
2014
Q1 | $6.32M | Buy |
89,210
+20,248
| +29% | +$1.59M | 0.05% | 280 |
|
|
2013
Q4 | $5.18M | Sell |
68,962
-182
| -0.3% | -$12.7K | 0.04% | 282 |
|
|
2013
Q3 | $4.34M | Sell |
69,144
-12,655
| -15% | -$756K | 0.04% | 290 |
|
|
2013
Q2 | $4.19M | Buy |
+81,799
| New | +$4.26M | 0.04% | 291 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Robeco Institutional Asset Management's GILD Position: Q2 2026 in Review
Robeco Institutional Asset Management increased its Gilead Sciences (GILD) stake by 3.1% in Q2 2026, buying an estimated $13.9M and bringing the position to 3,459,893 shares worth $437M. The position accounts for 0.54% of the portfolio, ranked #35.
Robeco Institutional Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $468M in Q1 2026. 585 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Robeco Institutional Asset Management held 3,459,893 shares of Gilead Sciences worth $437M as of Q2 2026.
- Robeco Institutional Asset Management bought 105,499 Gilead Sciences shares in Q2 2026, an estimated $13.9M.
- Gilead Sciences made up 0.54% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #35 holding.
- Robeco Institutional Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Robeco Institutional Asset Management's Gilead Sciences position peaked at $468M in Q1 2026.
- 585 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.